Activating a protein may treat dementia

Alzheimer; News from the web:

Associative memory is necessary to relate and remember situations, places and people at long term. This new study shows that a protein called CRTC1, which regulates genes essential for neuron function, needs to be activated in the hippocampus so that associative memory can be processed and stored.

Read all about it HERE

Stay on that computer!

Alzheimer; News from the web:

The Mayo clinic has done some interesting research, here is what they found:

Researchers have found that engaging in mentally stimulating activities, even late in life, may protect against new-onset mild cognitive impairment, which is the intermediate stage between normal cognitive aging and dementia. The study found that cognitively normal people 70 or older who engaged in computer use, craft activities, social activities and playing games had a decreased risk of developing mild cognitive impairment.

Read all about it HERE and HERE

SAK3 may offer hope to Alzheimer’s disease patients

Alzheimer; News from the web:

It is the name of a new drug, developed by the Japanese research group led by Tohoku University Professor Kohji Fukunaga. SAK3, stimulates the release of acetylcholine in the brain and improves cognition by activating the memory molecule CaMKII. According to Professor Fukunaga, SAK3 also reduces the production of amyloid beta protein in the study’s model mice.

Read all about it HERE

Mushrooms the anti-Alzheimer’s superfood?

Alzheimer; News from the web:

Mushrooms could be the food that protects you from Alzheimer’s disease, a new study claims.

Scientists have found that mushrooms contain bioactive compounds that could play a role in reducing or delaying the development of neurodegeneration.

Read all about it HERE

Alzheimer; News from the web:

Promising, early studies of deep brain stimulation (DBS) for the treatment of Alzheimer’s disease have paved a path for future clinical trials, but there are unique ethical challenges with this vulnerable population regarding decision making and post-study treatment access that need to be addressed as they ramp up, researchers argue.

Read all about it HERE